Connection

ANNA MALOVANNAYA to Cyclin-Dependent Kinases

This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Cyclin-Dependent Kinases.
Connection Strength

0.222
  1. Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 02 06; 145(6):612-624.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.